Clinical Trials Browser

Phase 1 × dalpiciclib × Breast × Clear all

NCT05586841 2026-05-29

Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study

Phase 1 Completed

HR+/HER2- Advanced Breast Cancer

NCT05515289 2023-03-10

Study of SHR6390 in Renal Insufficiency and Healthy Subjects

Phase 1 Unknown

Breast Neoplasms